References
- Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005;352:2082-90. https://doi.org/10.1056/NEJMoa044113
- Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis 2014;1:ofu024.
- Almirall J, Serra-Prat M, Bolibar I, Balasso V. Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies. Respiration 2017;94:299-311. https://doi.org/10.1159/000479089
- Liao WC, Lin CL, Shen TC, Tu CY, Hsia TC, Hsu WH. Risk of pleural empyema in adult patients with asthma: a nationwide retrospective cohort study. Front Med (Lausanne) 2022;9:851573.
- Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bonnelykke K, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007;357:1487-95. https://doi.org/10.1056/NEJMoa052632
- Fahy JV, Corry DB, Boushey HA. Airway inflammation and remodeling in asthma. Curr Opin Pulm Med 2000;6:15-20. https://doi.org/10.1097/00063198-200001000-00004
- Mitsi E, Roche AM, Reine J, Zangari T, Owugha JT, Pennington SH, et al. Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage. Mucosal Immunol 2017;10:385-94. https://doi.org/10.1038/mi.2016.71
- Sullivan A, Hunt E, MacSharry J, Murphy DM. 'The microbiome and the pathophysiology of asthma'. Respir Res 2016;17:163.
- Message SD, Johnston SL. Host defense function of the airway epithelium in health and disease: clinical background. J Leukoc Biol 2004;75:5-17. https://doi.org/10.1189/jlb.0703315
- McKeever T, Harrison TW, Hubbard R, Shaw D. Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. Chest 2013;144:1788-94. https://doi.org/10.1378/chest.13-0871
- Qian CJ, Coulombe J, Suissa S, Ernst P. Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study. Br J Clin Pharmacol 2017;83:2077-86. https://doi.org/10.1111/bcp.13295
- Kim MH, Rhee CK, Shim JS, Park SY, Yoo KH, Kim BY, et al. Inhaled corticosteroids in asthma and the risk of pneumonia. Allergy Asthma Immunol Res 2019;11:795-805. https://doi.org/10.4168/aair.2019.11.6.795
- Ekbom E, Quint J, Scholer L, Malinovschi A, Franklin K, Holm M, et al. Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia. BMC Pulm Med 2019;19:254.
- O'Byrne PM, Pedersen S, Carlsson LG, Radner F, Thoren A, Peterson S, et al. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med 2011;183:589-95. https://doi.org/10.1164/rccm.201005-0694OC
- Festic E, Bansal V, Gajic O, Lee AS; United States Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS). Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study. Mayo Clin Proc 2014;89:154-62. https://doi.org/10.1016/j.mayocp.2013.10.028
- Bansal V, Mangi MA, Johnson MM, Festic E. Inhaled corticosteroids and incident pneumonia in patients with asthma: systematic review and meta-analysis. Acta Med Acad 2015;44:135-58. https://doi.org/10.5644/ama2006-124.141
- McKeever T, Mortimer K, Bradshaw L, Haydock R, Pavord I, Higgins B, et al. Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST. Health Technol Assess 2018;22:1-82. https://doi.org/10.3310/hta22700
- Kendzerska T, Aaron SD, To T, Licskai C, Stanbrook M, Vozoris NT, et al. Effectiveness and safety of inhaled corticosteroids in older individuals with chronic obstructive pulmonary disease and/or asthma. a population study. Ann Am Thorac Soc 2019;16:1252-62. https://doi.org/10.1513/AnnalsATS.201902-126OC
- Htun ZM, Aldawudi I, Katwal PC, Jirjees S, Khan S. Inhaled corticosteroids as an associated risk factor for asthmatic pneumonia: a literature review. Cureus 2020;12:e8717.
- Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs 2006;66:2235-54. https://doi.org/10.2165/00003495-200666170-00006
- Sheffer AL, Silverman M, Woolcock AJ, Diaz PV, Lindberg B, Lindmark B. Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. Ann Allergy Asthma Immunol 2005;94:48-54. https://doi.org/10.1016/S1081-1206(10)61285-9
- Souza-Machado C, Souza-Machado A, Franco R, Ponte EV, Barreto ML, Rodrigues LC, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J 2010;35:515-21. https://doi.org/10.1183/09031936.00101009
- Rabe KF, Pizzichini E, Stallberg B, Romero S, Balanzat AM, Atienza T, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006; 129:246-56. https://doi.org/10.1378/chest.129.2.246
- Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med 2019;380:2020-30. https://doi.org/10.1056/NEJMoa1901963
- To M, To Y, Yamada H, Ogawa C, Otomo M, Suzuki N, et al. Influence of inhaled corticosteroids on community-acquired pneumonia in patients with bronchial asthma. Intern Med 2004;43:674-8. https://doi.org/10.2169/internalmedicine.43.674
- Terraneo S, Polverino E, Cilloniz C, Amaro R, Vennera Mdel C, Gabarrus A, et al. Severity and outcomes of community acquired pneumonia in asthmatic patients. Respir Med 2014;108:1713-22. https://doi.org/10.1016/j.rmed.2014.09.001
- Lee SC, Son KJ, Han CH, Jung JY, Park SC. Association between inhaled corticosteroid use and SARS-CoV-2 infection: a nationwide population-based study in South Korea. Tuberc Respir Dis (Seoul) 2022;85:80-8. https://doi.org/10.4046/trd.2021.0102
- Patel R, Naqvi SA, Griffiths C, Bloom CI. Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review. BMJ Open Respir Res 2020;7:e000756.